Search Results - "HEEMSKERK, Mirjam H. M"

Refine Results
  1. 1

    Reassessing human MHC-I genetic diversity in T cell studies by Slieker, Roderick C., Warmerdam, Daniël O., Vermeer, Maarten H., van Doorn, Remco, Heemskerk, Mirjam H. M., Scheeren, Ferenc A.

    Published in Scientific reports (04-04-2024)
    “…The Major Histocompatibility Complex class I (MHC-I) system plays a vital role in immune responses by presenting antigens to T cells. Allele specific…”
    Get full text
    Journal Article
  2. 2

    Mixed T cell receptor dimers harbor potentially harmful neoreactivity by van Loenen, Marleen M., de Boer, Renate, Amir, Avital L., Hagedoorn, Renate S., Volbeda, Gerdien L., Willemze, Roelof, van Rood, Johannes J., Falkenburg, J. H. Frederik, Heemskerk, Mirjam H. M.

    “…Adoptive transfer of T cell receptor (TCR)-transduced T cells may be an attractive strategy to target both hematological malignancies and solid tumors. By…”
    Get full text
    Journal Article
  3. 3
  4. 4

    SARS-CoV-2-specific CD4 + and CD8 + T cell responses can originate from cross-reactive CMV-specific T cells by Pothast, Cilia R, Dijkland, Romy C, Thaler, Melissa, Hagedoorn, Renate S, Kester, Michel G D, Wouters, Anne K, Hiemstra, Pieter S, van Hemert, Martijn J, Gras, Stephanie, Falkenburg, J H Frederik, Heemskerk, Mirjam H M

    Published in eLife (21-11-2022)
    “…Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific CD4 and CD8 T cells in SARS-CoV-2-unexposed donors has been explained by the…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations by Hombrink, Pleun, Hadrup, Sine R, Bakker, Arne, Kester, Michel G D, Falkenburg, J H Frederik, von dem Borne, Peter A, Schumacher, Ton N M, Heemskerk, Mirjam H M

    Published in PloS one (05-08-2011)
    “…T-cell recognition of minor histocompatibility antigens (MiHA) plays an important role in the graft-versus-tumor (GVT) effect of allogeneic stem cell…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Inhibition of SUMOylation enhances DNA hypomethylating drug efficacy to reduce outgrowth of hematopoietic malignancies by Kroonen, Jessie S., de Graaf, Ilona J., Kumar, Sumit, Remst, Dennis F. G., Wouters, Anne K., Heemskerk, Mirjam H. M., Vertegaal, Alfred C. O.

    Published in Leukemia (01-04-2023)
    “…Combination therapies targeting malignancies aim to increase treatment efficacy and reduce toxicity. Hypomethylating drug 5-Aza-2’-deoxycytidine (5-Aza-2’)…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity by Zhang, Yi, Liu, Yeuying, Moxley, Kelly M, Golden-Mason, Lucy, Hughes, Michael G, Liu, Tongxin, Heemskerk, Mirjam H M, Rosen, Hugo R, Nishimura, Michael I

    Published in PLoS pathogens (01-07-2010)
    “…Hepatitis C Virus (HCV) is a major public health concern, with no effective vaccines currently available and 3% of the world's population being infected…”
    Get full text
    Journal Article
  13. 13

    Allo-HLA reactivity of virus-specific memory T cells is common by Amir, Avital L, D'Orsogna, Lloyd J.A, Roelen, Dave L, van Loenen, Marleen M, Hagedoorn, Renate S, de Boer, Renate, van der Hoorn, Menno A.W.G, Kester, Michel G.D, Doxiadis, Ilias I.N, Falkenburg, J. H. Frederik, Claas, Frans H.J, Heemskerk, Mirjam H.M

    Published in Blood (15-04-2010)
    “…Graft-versus-host disease and graft rejection are major complications of allogeneic HLA-mismatched stem cell transplantation or organ transplantation that are…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure by Wachsmann, Tassilo L. A., Wouters, Anne K., Remst, Dennis F. G., Hagedoorn, Renate S., Meeuwsen, Miranda H., van Diest, Eline, Leusen, Jeanette, Kuball, Jürgen, Falkenburg, J. H. Frederik, Heemskerk, Mirjam H. M.

    Published in Oncoimmunology (31-12-2022)
    “…Chimeric antigen receptor (CAR) T cell therapies have resulted in profound clinical responses in the treatment of CD19-positive hematological malignancies, but…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Functional Human Antigen-Specific T Cells Produced In Vitro Using Retroviral T Cell Receptor Transfer into Hematopoietic Progenitors by van Lent, Anja U, Nagasawa, Maho, van Loenen, Marleen M, Schotte, Remko, Schumacher, Ton N. M, Heemskerk, Mirjam H. M, Spits, Hergen, Legrand, Nicolas

    Published in Journal of Immunology (15-10-2007)
    “…In vitro production of human T cells with known Ag specificity is of major clinical interest for immunotherapy against tumors and infections. We have performed…”
    Get full text
    Journal Article